Core Scientific, Inc.
18.09USD
-0.6400 (-3.42%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 640.3M | 502.4M | 510.7M | 319.0M | 671.6M | 1.2B |
| Q1 | 192.5M | 120.7M | 179.3M | 79.5M | 115.2M | — |
| Q2 | 164.0M | 126.9M | 141.1M | 78.6M | 164.2M | — |
| Q3 | 162.6M | 112.9M | 95.4M | 81.1M | 192.7M | — |
| Q4 | 121.3M* | 141.9M* | 94.9M | 79.8M* | 204.7M | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | -6.30 | -.650 | -4.87 | -.880 | -3.88 | .140 |
| Q1 | -1.52 | .000 | .780 | 1.24 | -1.06 | — |
| Q2 | -2.49 | -.020 | -5.05 | -.040 | -3.32 | — |
| Q3 | -1.23 | -.110 | -1.17 | -.450 | -.040 | — |
| Q4 | -1.28* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| -.515* |
| -.690 |
| .679* |
| -.055 |
| — |